Effects of Antidepressants on Sexual Functioning

PHASE3CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG

Extended-Release Bupropion Hydrochloride

Trial Locations (23)

10021

GSK Investigational Site, New York

20852

GSK Investigational Site, Rockville

21208

GSK Investigational Site, Baltimore

22908

GSK Investigational Site, Charlottesville

23294

GSK Investigational Site, Richmond

29407

GSK Investigational Site, Charleston

32216

GSK Investigational Site, Jacksonville

33065

GSK Investigational Site, Coral Springs

43623

GSK Investigational Site, Toledo

44109

GSK Investigational Site, Cleveland

46202

GSK Investigational Site, Indianapolis

47802

GSK Investigational Site, Terre Haute

53719

GSK Investigational Site, Madison

55454

GSK Investigational Site, Minneapolis

74135

GSK Investigational Site, Tulsa

77401

GSK Investigational Site, Bellaire

90210

GSK Investigational Site, Beverly Hills

91942

GSK Investigational Site, La Mesa

92056

GSK Investigational Site, Oceanside

94709

GSK Investigational Site, Berkeley

97210

GSK Investigational Site, Portland

97401

GSK Investigational Site, Eugene

02865-4208

GSK Investigational Site, Lincoln

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY